Connection

Marco Metra to Risk Factors

Back to Details
This is a "connection" page, showing publications Marco Metra has written about Risk Factors.
Marco Metra
Connection Strength
0.362
Risk Factors
  1. Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study. Europace. 2021 10 09; 23(10):1603-1611.
    View in: PubMed
    Score: 0.029
  2. Thrombotic risk in patients with COVID-19. Rev Cardiovasc Med. 2021 06 30; 22(2):277-286.
    View in: PubMed
    Score: 0.029
  3. Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study. Clin Res Cardiol. 2021 Jul; 110(7):1020-1028.
    View in: PubMed
    Score: 0.027
  4. Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk? Eur Heart J. 2020 07 01; 41(32):3094.
    View in: PubMed
    Score: 0.027
  5. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020 05 14; 41(19):1821-1829.
    View in: PubMed
    Score: 0.026
  6. Focus on echocardiographic right ventricular strain analysis in cystic fibrosis adults without cardiovascular risk factors: a case-control study. Intern Emerg Med. 2019 11; 14(8):1279-1285.
    View in: PubMed
    Score: 0.025
  7. Sacubitril/valsartan: from a large clinical trial to clinical practice. J Cardiovasc Med (Hagerstown). 2018 Sep; 19(9):473-479.
    View in: PubMed
    Score: 0.024
  8. April 2018 at a glance: focus on prognostic variables. Eur J Heart Fail. 2018 04; 20(4):625-626.
    View in: PubMed
    Score: 0.023
  9. What will be the impact of sacubitril/valsartan in clinical practice? J Cardiovasc Med (Hagerstown). 2018 Feb; 19 Suppl 1:e88-e90.
    View in: PubMed
    Score: 0.023
  10. Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial. Am Heart J. 2017 May; 187:62-69.
    View in: PubMed
    Score: 0.021
  11. Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study. JAMA Cardiol. 2020 Nov 01; 5(11):1274-1280.
    View in: PubMed
    Score: 0.007
  12. Coronavirus disease 2019 (COVID-19) in the heart transplant population: a single-centre experience. Eur J Cardiothorac Surg. 2020 11 01; 58(5):899-906.
    View in: PubMed
    Score: 0.007
  13. ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes. Circulation. 2020 06 23; 141(25):2113-2116.
    View in: PubMed
    Score: 0.007
  14. Medical misinformation: vet the message! Eur Heart J Cardiovasc Pharmacother. 2019 04 01; 5(2):62-63.
    View in: PubMed
    Score: 0.006
  15. EkoSonic Endovascular System for patients with acute pulmonary embolism and contraindication to systemic fibrinolysis. J Cardiovasc Med (Hagerstown). 2019 Mar; 20(3):131-136.
    View in: PubMed
    Score: 0.006
  16. Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points. Circ Cardiovasc Qual Outcomes. 2018 10; 11(10):e004783.
    View in: PubMed
    Score: 0.006
  17. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database. Clin Exp Rheumatol. 2018 Jul-Aug; 36 Suppl 113(4):68-75.
    View in: PubMed
    Score: 0.006
  18. Echocardiographic evaluation of diastolic dysfunction in young and healthy patients with psoriasis: A case-control study. Monaldi Arch Chest Dis. 2018 09 04; 88(3):934.
    View in: PubMed
    Score: 0.006
  19. Waist-to-hip ratio and mortality in heart failure. Eur J Heart Fail. 2018 09; 20(9):1269-1277.
    View in: PubMed
    Score: 0.006
  20. Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosis. Rheumatology (Oxford). 2018 05 01; 57(5):813-817.
    View in: PubMed
    Score: 0.006
  21. Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group. Rheumatology (Oxford). 2018 03 01; 57(3):441-450.
    View in: PubMed
    Score: 0.006
  22. Review: Defining a Unified Vascular Phenotype in Systemic Sclerosis. Arthritis Rheumatol. 2018 02; 70(2):162-170.
    View in: PubMed
    Score: 0.006
  23. Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF. Eur J Heart Fail. 2018 02; 20(2):304-314.
    View in: PubMed
    Score: 0.006
  24. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017 11; 76(11):1897-1905.
    View in: PubMed
    Score: 0.005
  25. Preoperative cardiac risks in noncardiac surgery: The role of coronary angiography. Monaldi Arch Chest Dis. 2017 07 18; 87(2):863.
    View in: PubMed
    Score: 0.005
  26. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial. J Am Coll Cardiol. 2017 Jun 27; 69(25):3029-3039.
    View in: PubMed
    Score: 0.005
  27. Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure. Eur J Heart Fail. 2017 05; 19(5):627-634.
    View in: PubMed
    Score: 0.005
  28. A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial. Eur J Heart Fail. 2017 08; 19(8):1001-1010.
    View in: PubMed
    Score: 0.005
  29. Measurement of the myocardial performance index in ambulatory patients with heart failure: correlation with other clinical and echocardiographic parameters and independent prognostic value. Echocardiography. 2010 Feb; 27(2):123-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.